Close
FINDING CURES TOGETHER<sup>SM</sup>

Pediatric Cancer Working Group at the Annual Meeting

The AACR Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. All attendees are encouraged to take advantage of the opportunities presented at the meeting to learn about the latest advances in pediatric cancer research, attend sessions outside your own areas of expertise, and network with other scientists and clinicians.

PCWG Events at the AACR Annual Meeting 2019

Pediatric Cancer Working Group Town Hall Meeting and Networking Reception 
Sunday, March 31, 2019 
6:30 p.m.- 8:30 p.m.
Atlanta Marriott Marquis, Imperial Room AB
Chairperson:
Crystal L. Mackall, MD, Stanford University School of Medicine, Stanford, California
Chairperson-elect:
Kimberly Stegmaier, MD, Dana-Farber Cancer Institute, Boston, Massachusetts

All Annual Meeting attendees are invited to attend this special evening session hosted by the Pediatric Cancer Working Group. This session will include an update on all AACR pediatric cancer programs and initiatives and an interactive discussion on the current state of pediatric cancer drug discovery and development. Specifically, this session will explore both ongoing successes and challenges associated with pediatric cancer drug development, as well as discuss recent pediatric cancer-focused legislation. A networking reception will take place immediately following the session program.

Panelists:
Peter C. Adamson, MD, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Patricia Blanc, MS, Imagine for Margo, Fourqueux, France
Mark W. Kieran, MD, PhD, Bristol-Myers Squibb, Boston, Massachusetts
Andrew Pearson, PhD, Emeritus, Royal Marsden Hospital and Institute of Cancer Research, Sutton, England
Gregory H. Reaman, MD, U.S. Food and Drug Administration, Silver Springs, Maryland
Gilles Vassal, MD, PhD, Institute Gustave Roussy, Villejuif, France


Pediatric Cancer Working Group Regulatory Science and Policy Track Session
ACCELERATING Pediatric Drug Discovery and Approval
Held in Collaboration with the ACCELERATE Innovation for Children and Adolescents with Cancer Platform
Tuesday, April 2, 2019
10:30 a.m. - noon
Georgia World Congress Center, Room A402-403

Speakers:
Gilles Vassal, MD, PhD, Institute Gustave Roussy, Villejuif, France
Andrew Pearson, PhD, Emeritus, Royal Marsden Hospital and Institute of Cancer Research, Sutton, England
Mark W. Kieran, MD, PhD, Bristol-Myers Squibb, Boston, Massachusetts
Peter C. Adamson, MD, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Gregory H. Reaman, MD, U.S. Food and Drug Administration, Silver Springs, Maryland

Panelists:
Patricia Blanc, MS, Imagine for Margo, Fourqueux, France
Nancy F. Goodman, JD, Kids v. Cancer, Washington, D.C.
Susan L. Weiner, PhD, Children's Cause for Cancer Advocacy, Brooklyn, New York

Moderator:
Crystal L. Mackall, MD, Stanford University School of Medicine, Stanford, California


Pediatric Cancer Working Group Scientific Session: What's New? Rising Stars in Pediatric Oncology
CME-designated
Tuesday, April 2, 2019
1:00 p.m. - 3:00 p.m.
Georgia World Congress Center, C302
Chairperson and Moderator:
Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts

This session will include presentations from past AACR pediatric cancer grant recipients as they highlight the research advancements that have been made possible by AACR-administered scientific grant funding.

Speakers:

“Fusion oncogenes co-opt developmental programs for rhabdomyosarcoma tumorigenesis”
Genevieve C. Kendall, PhD, University of Texas Southwestern Medical Center

“Implications of T Cell Variance in Pediatric Immunotherapy”
David M. Barrett, MD, PhD, Children’s Hospital of Philadelphia 

“Initiation of FN-RMS from Endothelial Progenitors”
Catherine Drummond, PhD, University of Otego

“Discovery and development of GPC2 as an immunotherapeutic target in neuroblastoma and other cancers”
Kristopher R. Bosse, MD, Children's Hospital of Philadelphia

“Driver oncogenes specify differential requirements for GATOR2-mTORC1 activation in rhabdomyosarcoma”
Amit J. Sabnis, MD, University of California, San Francisco

Visit the AACR Annual Meeting homepage for more information about the meeting.


Access the links below to view previous PCWG annual meeting events: